SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-22-008814
Filing Date
2022-08-18
Accepted
2022-08-18 15:56:47
Documents
1
Period of Report
2022-08-17

Document Format Files

Seq Description Document Type Size
1 form4-08182022_120836.html 4  
1 form4-08182022_120836.xml 4 4422
  Complete submission text file 0001415889-22-008814.txt   5891
Mailing Address 343 ALLERTON AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address 343 ALLERTON AVENUE SOUTH SAN FRANCISCO CA 94080 650-577-3600
VistaGen Therapeutics, Inc. (Issuer) CIK: 0001411685 (see all company filings)

IRS No.: 205093315 | State of Incorp.: NV | Fiscal Year End: 0331
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O VISTAGEN THERAPEUTICS, INC. 343 ALLERTON AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address
Singh Shawn (Reporting) CIK: 0001412071 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37761 | Film No.: 221177477